CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishInhibitors of Poly(ADP-ribose) polymerases (PARPs) have been proposed as promising chemotherapeutic agents in inflammatory, degenerative, and neoplastic diseases. To further substantiate this proposal, we tested the biomolecular effects of PARP-1 inhibitors DPQ and PJ34 on human glioblastoma (GBM) cells, induced to a proinflammatory state with Lipopolysaccharide (LPS) and Interferon-γ (INF-γ). PARP-1 expression was evaluated by laser scanning confocal microscopy (LSM); nitrite production, LDH release, cell viability were also determined. LSM of A172, SNB-19, CAS-1 cells demonstrated that DPQ and PJ34 downregulate PARP-1 expression; they also cause a decrease of LDH release and nitrite production, while increasing cell viability. Similar effects were caused in all three cell lines also by N-mono-methyl-arginine (NMMA), a well known iNOS inhibitor, and by L-carnosine and trehalose, two antioxidant molecules. These results demonstrate that, similar to other well characterised drugs, DPQ and PJ34 reduce cell inflammation and damage ensuing PARP-1 overexpression, while they increase cell survival: this suggests their potential exploitation in clinical Medicine.
| Titolo: | PARP-1 Inhibitors DPQ and PJ-34 Negatively Modulate Proinflammatory Commitment of Human Glioblastoma Cells. |
| Autori interni: | |
| Data di pubblicazione: | 2013 |
| Rivista: | |
| Handle: | http://hdl.handle.net/20.500.11769/13187 |
| Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Copyright © 2020